References
- Abdel-Kader K. Unruh M.L. Weisbord S.D. (2009). Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clin J Am Soc Nephrol. 4: 1057-1064.
- Bitran JD, Desser RK, Billings AA, Kozloff MF, Shapiro CM. (1982). Acute nephrotoxicity following cis-dichlorodiammine-platinum. Cancer. 49:1784-1788.
- Bubis L.D. Davis L. Mahar A. et al. (2018). Symptom burden in the first Year after cancer Diagnosis: An Analysis of patient-Reported outcomes. J Clin Oncol. 36: 1103-1111.
- Crawford J. Cella D. Cleeland C.S. et al. (2002). Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer. 95: 888-895.
- Dai, L., Golembiewska, E., Lindholm, B., and Stenvinkel, P. (2017). End-Stage Renal Disease, Inflammation and Cardiovascular Outcomes, in Expanded Hemodialysis: Innovative Clinical Approach in Dialysis, 32–43. doi:10.1159/000479254 .
- De Cavanagh, E. M. V., Piotrkowski, B., and Fraga, C. G. (2004). Concerted Action of the Renin-Angiotensin System, Mitochondria, and Antioxidant Defenses in Aging. Mol. Aspects Med. 25, 27–36. doi: 10.1016/j.mam.2004.02.006
- Ebert, T., Pawelzik, S.-C., Witasp, A., Arefin, S., Hobson, S., Kublickiene, K., et al. (2020). Inflammation and Premature Ageing in Chronic Kidney Disease. Toxins 12, 227. doi:10.3390/toxins12040227
- Garcia J.M. Li H. Mann D. et al. (2006). Hypogonadism in male patients with cancer. Cancer. 106: 2583-2591.
- Gelfand S.L. Schell J.O. Eneanya N.D. (2020). Palliative care in nephrology: the Work and the Workforce.Adv Chronic Kidney Dis. 27: 350-355.
- Gelfand S.L. Scherer J.S. Koncicki H.M. (2020). Kidney supportive care: Core Curriculum 2020. Am J Kidney Dis.75: 793-806.
- Inker L.A., Schmid C.H., Tighiouart H. (2012). Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 367:20–29.
- Jager K.J., Kovesdy C., Langham R., et al (2019). Asingle number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 96:1048–1050.
- Liu L., Zhu M., Meng Q. (2020). Association between kidney function and the risk of cancer: results from the China health and retirement longitudinal study (Charls) J Cancer. 11:6429–6436.
- Lees JS, Ho F, Parra-Soto S et al. (2021). Kidney function and cancer risk: an analysis using creatinine and cystatin C in a cohort study. EClinicalMedicine. 38: 101030.
- Masereeuw, R., Mutsaers, H. A. M., Toyohara, T., Abe, T., Jhawar, S., Sweet, D. H., et al. (2014). The Kidney and Uremic Toxin Removal: Glomerulus or Tubule? Seminars Nephrol.34, 191–208. doi:10.1016/j.semnephrol.2014.02.010.
- Mok Y, Matsushita K, Sang Y et al. (2016). Association of kidney disease measures with cause-specific mortality: the Korean Heart Study. PLoS One 11: e0153429.
- Mok Y., Ballew S.H., Sang Y. (2020). Albuminuria, kidney function, and cancer risk in the community. Am J Epidemiol.189:942–950.
- Paladino J. Lakin J.R. Sanders J.J. (2019). Communication strategies for sharing prognostic information with patients: beyond survival statistics. JAMA. 322: 1345-1346.
- Putri, A. Y., and Thaha, M. (2014). Role of Oxidative Stress on Chronic Kidney Disease Progression. Acta Med. Indones. 46, 244–252.
- Tarricone R. Ricca G. Nyanzi-Wakholi B. Medina-Lara A. (2016). Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilization: a systematic review. Crit Rev Oncol Hematol. 99: 49-62.
- Tu H, Wen CP, Tsai SP et al. (2018). Cancer risk associated with chronic diseases and disease markers: prospective cohort study. BMJ. 360: k134. doi: 10.1136/bmj.k134.
- Santos MLC, Brito BB, da Silva FAF, Botelho ACDS, Melo FF. (2020). Nephrotoxicity in cancer treatment: An overview. World J Clin Oncol. 11(4): 190-204.
- Sevilya, Z., Leitner-Dagan, Y., Pinchev, M., Kremer, R., Elinger, D., Rennert, H. S., et al. (2014). Low Integrated DNA Repair Score and Lung Cancer Risk. Cancer Prev. Res. 7, 398–406. doi: 10.1158/1940-6207.CAPR-13-0318.
- Weng PH, Hung KY, Huang HL et al. (2011). Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol. 6: 1121–1128.